XML 76 R48.htm IDEA: XBRL DOCUMENT
v3.22.2

Investments in Other Entities - Equity Method Investments (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Sep. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | $ 41,715 |
Allocation of Income (Loss) |  | $ 1,512 | $ (3,134) | 2,945 | $ (3,812)
Funding reclassified to loan receivable |  |  |  | (2,125) |
Funding |  |  |  | 1,685 |
Distribution |  |  |  | (400) |
Ending Balance |  | 43,820 |  | 43,820 |
LaSalle Medical Associates – IPA Line of Business |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | 3,034 |
Allocation of Income (Loss) |  |  |  | 2,535 |
Funding reclassified to loan receivable |  |  |  | (2,125) |
Funding |  |  |  | 0 |
Distribution |  |  |  | 0 |
Ending Balance |  | 3,444 |  | 3,444 |
Pacific Medical Imaging & Oncology Center, Inc. |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | 1,719 |
Allocation of Income (Loss) |  |  |  | 22 |
Funding reclassified to loan receivable |  |  |  | 0 |
Funding |  |  |  | 0 |
Distribution |  |  |  | 0 |
Ending Balance |  | 1,741 |  | 1,741 |
531 W. College, LLC – related party |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | 17,230 |
Allocation of Income (Loss) |  |  |  | (305) |
Funding reclassified to loan receivable |  |  |  | 0 |
Funding |  |  |  | 250 |
Distribution |  |  |  | 0 |
Ending Balance |  | 17,175 |  | 17,175 |
One MSO, LLC – related party |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | 2,910 |
Allocation of Income (Loss) |  | 100 | $ 100 | 254 | $ 200
Funding reclassified to loan receivable |  |  |  | 0 |
Funding |  |  |  | 0 |
Distribution |  |  |  | (400) |
Ending Balance |  | 2,764 |  | 2,764 |
Tag-6 Medical Investment Group, LLC – related party |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance |  |  |  | 4,830 |
Allocation of Income (Loss) |  |  |  | 111 |
Funding reclassified to loan receivable |  |  |  | 0 |
Funding |  |  |  | 1,435 |
Distribution |  |  |  | 0 |
Ending Balance |  | 6,376 |  | 6,376 |
CAIPA MSO, LLC |  |  |  |  |
Equity Method Investments [Roll Forward] |  |  |  |  |
Beginning Balance | $ 11,700 |  |  | 11,992 |
Allocation of Income (Loss) |  | 200 |  | 328 |
Funding reclassified to loan receivable |  |  |  | 0 |
Funding |  |  |  | 0 |
Distribution |  |  |  | 0 |
Ending Balance |  | $ 12,320 |  | $ 12,320 |

X
- Definition Equity Method Investment, Reclassification + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentReclassification
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments, Contribution + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsContribution
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments [Roll Forward] + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsRollForward
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the entity's equity method investment which has been sold. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSoldCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCRelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |